Quarterly Results
DHC Earnings Forecast
Looking ahead, DHC remains a focal point for investors seeking growth opportunities. Analyst forecasts for project quarter revenue of and an EPS of undefined.
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been No Change by 0%, while EPS estimates have been No Change by 0%. For the upcoming , revenue estimates have been adjusted Go Up by 45.45% . These revisions correlate with a % change in stock price over the same period, suggesting potential buying opportunities for investors who believe in DHC long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
1Y
3Y
5Y
Currency: USD
--
Revenue Estimate-:0
--
EPS Estimate-:0
—
Stock Price0
Revenue Estimates for FY2025
No Change
0.00%
In Past 3 Month
Revenue Estimates for Q2 2025
No Change
0.00%
In Past 3 Month
Unlock the reason behind revisions!
Stock Price
Go Up
+45.45%
In Past 3 Month
No data
Earnings Surprise Analysis
Revenue
EPS
1Y
3Y
Al Analysis
Earnings Reaction
The chart below shows how DHC performed 10 days before and after its earnings report, based on data from the past quarters. Typically, DHC sees a -4.22% change in stock price 10 days leading up to the earnings, and a +9.19% change 10 days following the report. On the earnings day itself, the stock moves by +0.66%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in SEP/2025, the stock changed -4.86% on the day following the earnings release and then changed by 4.30% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
People Also Watch
Frequently Asked Questions
What were the key highlights of DHC's latest earnings report for ?
DHC reported its earnings on 2025-11-03, showcasing a revenue of 388.71M against an estimate of 387.15M, resulting in a 0.4% surprise. The EPS was 0.04, surpassing the expected 0.08 by -50% . The stock experienced a -4.86% price change on the earnings day and a 1.13% change over the next five days, reflecting market reactions to the results.
How did DHC's stock price react after the earnings release?
Following DHC's earnings announcement on 2025-11-03, the stock price moved by -4.86% on the day of the release. Over the subsequent five days, it saw a 1.13% change. Historically, DHC's stock price tends to shift by an average of -4.22% in the 10 days leading up to earnings and +9.19% in the 10 days following, providing insight into potential market.
What are the revenue and EPS estimates for DHC for undefined?
For , analysts estimate DHC’s annual revenue to reach , while the EPS is projected at undefined. These estimates reflect recent revisions, with revenue estimates revised Revenue No Change by 0% and EPS estimates Go Up by 45.45% over the past three months, indicating analyst expectation in the company’s performance.
How does DHC's stock price correlate with earnings forecast revisions?
The correlation between DHC's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were No Change by 0%, while EPS estimates moved Go Up by 45.45% . This trend suggests that price dips could present buying opportunities for investors.
What should investors expect from DHC's next earnings report?
Based on historical trends, DHC's stock price typically moves by -4.22% in the 10 days before its earnings and +9.19% in the 10 days after. For the upcoming earnings, analysts expect an EPS of undefined and revenue of .
What is the sentiment in Diversified Healthcare Trust (DHC) Q3 2025 Earnings Call Summary?
The earnings call highlights positive financial performance with increased revenues, NOI, and occupancy across various segments. Despite temporary labor cost increases, the company maintains strong guidance and expects favorable transitions. The Q&A section reveals management's confidence in achieving targets and mitigating risks. The increase in SHOP NOI guidance and active disposition pipeline further support a positive outlook. However, the lack of specific details on potential revenue disruptions and disposition delays warrants caution. Overall, the sentiment leans towards positive due to strong financial metrics and optimistic guidance.